Emerging technologies like AI and robotics have vast potential to improve healthcare. Few question this. What remains unclear is how meaningful the advances will be to healthcare providers and, more to the point, the patients they serve.

Civica Rx, a not-for-profit drug company with $100 million in funding that aims to combat drug shortages, has inked its next deal with Exela Pharma Sciences to supply its membership of hospitals with sodium bicarbonate injections.

Two major companies are joining forces in a 10-year strategic partnership to accelerate healthcare innovation through digital technologies.

Geisinger has tapped IBM’s AI expertise and come up with a way to predict hospital patients’ risk of sepsis. In the process, the method can increase chances of survival in those who have the tricky and potentially life-threatening condition.

A single heartbeat is all a new neural-network technique needs to detect heart failure with 100% accuracy, according to a study slated for January 2020 publication in Biomedical Signal Processing and Control Journal.

Researchers have developed a system combining AI and mHealth to catch signs of impending suicidal behavior in time for interventions by caregivers.

An AI-based smartphone app for detecting cancer in skin lesions has proven quite capable, achieving 95.1% sensitivity.

Intermountain Healthcare has opened an AI-powered service line for patients with chronic kidney disease and end-stage renal disease.